Pharma Inc in a huddle after fresh NMC norms
Business Standard|August 14, 2023
Says prescription of generic drugs could impact quality and patient safety
SOHINI DAS
Pharma Inc in a huddle after fresh NMC norms

With the National Medical Commission (NMC) making it mandatory for doctors to prescribe generic names for drugs, pharma industry groups are in a huddle over questions of quality and safety.

A senior executive of a prominent lobby group said the fresh regulations were being examined. "If doctors prescribe only generic molecule names, then there may be an issue with quality. With a branded generic there comes a quality assurance and thus this is critical for patient safety," the person said.

"There are over 10,000 manufacturers of medicines in the country, and not all of them follow the same quality guidelines. Therefore, with such a move, who takes responsibility for quality and patient safety will the doctor be accountable?" he added. Further, once the doctor prescribes the molecule name, the chemist will choose which brand to give the patient, said pharma industry insiders.

"Power thus shifts to chemists instead of doctors. Whichever company offers better incentives, the chemist would prefer it," the industry feared.

This story is from the August 14, 2023 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the August 14, 2023 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS STANDARDView All
Business Standard

Thyssen JV in fray for building 6 conventional subs

The global tender for building six state-of-theart conventional submarines for the Indian Navy has boiled down to a contest between two joint ventures (JVs).

time-read
1 min  |
July 13, 2024
THE REAL RAILWAY MEN
Business Standard

THE REAL RAILWAY MEN

As a debate rages on about the working conditions of railway loco drivers, here is a peek into their lives

time-read
4 mins  |
July 13, 2024
Why Anxiety is the new villain
Business Standard

Why Anxiety is the new villain

Pixar Animation Studios is breathing a sigh of relief.

time-read
3 mins  |
July 13, 2024
Low valuation and robust pipeline may fuel TCS rally
Business Standard

Low valuation and robust pipeline may fuel TCS rally

The shares of Tata Consultancy Services (TCS) zoomed over 6 per cent to ₹4,182 a piece on the BSE on Friday.

time-read
3 mins  |
July 13, 2024
MFs bought over ₹46,000 crore HDFC Bank shares in H1CY24
Business Standard

MFs bought over ₹46,000 crore HDFC Bank shares in H1CY24

Mutual funds bought HDFC Bank shares worth over 46,100 crore in the first six months of 2024, reversing the sell-off trend in the last three months of 2023, according to data from Nuvama Alternative Quantitative Research.

time-read
1 min  |
July 13, 2024
Business Standard

Rerating potential in Axis Bank stock

The April-June quarter (Q1) of the current financial year (FY25) may be soft for banks with loan growth moderation, net interest margin (NIM) pressures, and higher staff and credit costs inching up, according to analysts.

time-read
2 mins  |
July 13, 2024
Business Standard

Quant MF gets new CFO, says move unrelated to Sebi probe

Quant Mutual Fund (MF) has informed investors that its Chief Financial Officer (CFO) Harshal Patel has resigned \"due to personal reasons\".

time-read
1 min  |
July 13, 2024
Business Standard

Domestic MFs increase stake in Paytm, firm's FDI dips by 2%

One97 Communications, the company that operates Paytm, has recorded an increase in the shareholding of domestic investors, including mutual funds and retail shareholders, during the first quarter of financial year 202425 (Q1 FY25).

time-read
1 min  |
July 13, 2024
Business Standard

Top 25 global banks' mcap at $4.1trn in Q1

The combined market capitalisation (mcap) of the top 25 banks globally rose 5.4 per cent quarter-on-quarter (Q-oQ) during April-June 2024 (Q1 FY25) at $4.11 trillion, driven by favourable global economic signals, suggests a recent note by GlobalData, a Londonbased data analytics firm.

time-read
2 mins  |
July 13, 2024
Finfluencers feel the heat as Sebi crackdown looms
Business Standard

Finfluencers feel the heat as Sebi crackdown looms

Regulator shoots warning letters to 20 unauthorised investment advisors in 2 mths

time-read
2 mins  |
July 13, 2024